🇧🇪 Belgium Country × Condition
stroke Clinical Trials in Belgium
Active clinical trials for stroke with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇧🇪 Belgium
Active Trials in Belgium (5)
NCT06296082 Phase 2, Phase 3
Recruiting
Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity
Enrollment
90 pts
Country
🇧🇪 Belgium
Universiteit Antwerpen
View Trial → NCT07237386
Recruiting
Comparing the Ceriter Stride One, a Pressure-sensitive Smart Insole, With Gait Parameters Measured on the GRAIL in Neurological Populations
Enrollment
30 pts
Country
🇧🇪 Belgium
University Hospital, Ghent
View Trial → NCT06442579
Recruiting
The Influence of Cortical Lateralization on Selective Motor Control of the Arm Swing During Independent Walking After Stroke.
Enrollment
84 pts
Country
🇧🇪 Belgium
University Hospital, Ghent
View Trial → NCT04956185
Recruiting
Data Collection of Patients Admitted to the Stroke Unit
Enrollment
5,000 pts
Country
🇧🇪 Belgium
University Hospital, Ghent
View Trial → NCT05727111
Recruiting
Implementation of a HABIT-ILE Intervention at Home for Chronic Stroke
Enrollment
48 pts
Country
🇧🇪 Belgium
Université Catholique de Louvain
View Trial → Frequently Asked Questions
How many stroke clinical trials are active in Belgium?
There are currently 5 active clinical trials for stroke with sites in Belgium, of which 5 are actively recruiting patients.
How can I join a stroke clinical trial in Belgium?
To join a stroke clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are stroke trials in Belgium?
Active stroke trials in Belgium span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology